Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Patches are body heat activated, can use over hair or even clothing
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Regular monitoring, lab testing, and periodic reassessment are essential to reduce potential harm and identify early warning signs
PMID: 30551603 | DOI: 10.3390/molecules23123305 [9] De Rosa SC, Zaretsky MD, Dubs JG, et al
-1775582746855.png&w=3840&q=75)